Michael Fillitz

Heinrich Collin Str. 30
Vienna, 1140, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real-World International Experience.

Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real-World International Experience.

Journal: American journal of hematology

Published: January 30, 2026

Clinical evidence for antiglycoprotein IIbIIIa antibody-induced platelet desialylation in primary immune thrombocytopenia.

Clinical evidence for antiglycoprotein IIbIIIa antibody-induced platelet desialylation in primary immune thrombocytopenia.

Journal: Journal of thrombosis and haemostasis : JTH

Published: November 18, 2024

Management of Adult Patients with Newly Diagnosed or Relapsed Primary Immune Thrombocytopenia in Eastern Austria.

Management of Adult Patients with Newly Diagnosed or Relapsed Primary Immune Thrombocytopenia in Eastern Austria.

Journal: Hamostaseologie

Published: November 05, 2024

Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study.

Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study.

Journal: Blood

Published: October 17, 2024

Fibrinolysis is impaired in patients with primary immune thrombocytopenia.

Fibrinolysis is impaired in patients with primary immune thrombocytopenia.

Journal: Journal of thrombosis and haemostasis : JTH

Published: April 23, 2024

QoL during KTd or KRd induction followed by K maintenance or observation in transplant noneligible patients with newly diagnosed multiple myeloma: Longitudinal and cross-sectional analysis of the randomized AGMT 02 study.

QoL during KTd or KRd induction followed by K maintenance or observation in transplant noneligible patients with newly diagnosed multiple myeloma: Longitudinal and cross-sectional analysis of the randomized AGMT 02 study.

Journal: EJHaem

Published: February 12, 2024

Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma.

Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma.

Journal: American journal of hematology

Published: August 25, 2023

Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms.

Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms.

Journal: American journal of hematology

Published: November 30, 2022

Platelet function and soluble P-selectin in patients with primary immune thrombocytopenia.

Platelet function and soluble P-selectin in patients with primary immune thrombocytopenia.

Journal: Thrombosis research

Published: November 10, 2022

Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease.

Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease.

Journal: Blood advances

Published: July 15, 2022

Sustained sutimlimab response for 3 years in patients with cold agglutinin disease: A phase I, open-label, extension trial.

Sustained sutimlimab response for 3 years in patients with cold agglutinin disease: A phase I, open-label, extension trial.

Journal: British journal of haematology

Published: March 18, 2022

Practical considerations for the management of immune thrombocytopenic purpura.

Practical considerations for the management of immune thrombocytopenic purpura.

Journal: Memo

Published: July 05, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026